A new study led by Dr. Hilla Chen from the Koret School of Veterinary Medicine at Hebrew University, recently published in ...
Pariacalcitol is a type of vitamin D and is believed to be a positive way to manage CKD complications.
Excess parathyroid hormone due to over activity of parathyroid glands, four pea-sized glands located at the back of thyroid gland. Symptoms include loss of appetite, increased thirst and urination, ...
Clinical Trials Arena on MSN16d
AstraZeneca’s $1bn hypoparathyroidism drug achieves success at Phase IIIAstraZeneca acquired the hypoparathyroidism therapy eneboparatide as part of a buyout of Amolyt Pharma in July 2024.
People with unexpected osteoporosis should be considered for celiac disease testing. Celiac disease is a condition of damage ...
The study, published in the Journal of Veterinary Internal Medicine, examined the effects of paricalcitol -- a synthetic form ...
manifested by intact parathyroid hormone levels below normal. We aimed to evaluate intact parathyroid hormone levels both during normocalcemia and at hypocalcemia, in this population. Study Design ...
How well do injection protocols affect the progression of osteoporosis in bone? A new study from a group of Swiss researchers ...
A new study led by Dr. Hilla Chen, Prof. Gilad Segev and Dr. Michal Mazaki-Tovi from the Koret School of Veterinary Medicine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback